Per-Olov Eriksson

Title: Per-Olov Eriksson: Innovator in Heparin Derivatives

Introduction

Per-Olov Eriksson is a notable inventor based in Strängnäs, Sweden. He has made significant contributions to the field of biochemistry, particularly in the production of chemically-modified heparins. With a total of 3 patents, Eriksson's work has implications for medical treatments and pharmaceutical applications.

Latest Patents

Eriksson's latest patents include innovative processes for the production of heparin derivatives. One of his inventions focuses on a process for creating heparin derivatives with an average molecular weight ranging from about 4.6 to about 6.9 kDa and an anti-factor Xa activity of less than about 10 IU/mg. This process involves the oxidation of unfractionated heparin, followed by depolymerization and reduction of the resulting terminal groups. Another significant patent pertains to low anticoagulant heparins, which are chemically modified heparins with an anti-factor II activity of less than 10 IU/mg and an average molecular weight between about 6.5 and 9.5 kDa. This invention also includes a method for preparing the heparin and its medical use, particularly in the treatment of malaria.

Career Highlights

Throughout his career, Eriksson has worked with various companies, including Dilafor AB and Dilaforette AB. His expertise in the field has allowed him to develop innovative solutions that address critical medical needs.

Collaborations

Eriksson has collaborated with notable professionals in his field, including Erik Yngve Holmer and Hans-Peter Ekre. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Per-Olov Eriksson's contributions to the field of chemically-modified heparins highlight his innovative spirit and dedication to improving medical treatments. His patents reflect a commitment to advancing biochemistry and addressing important health challenges.